Skip to main content
. 2022 Jun 6;2022(6):CD011574. doi: 10.1002/14651858.CD011574.pub2

23.4. Analysis.

23.4

Comparison 23: Sensitivity analysis 3: excluding studies with unclear or high risk of bias on allocation concealment, Outcome 4: Number of fallers ‐ cholinesterase inhibitor vs placebo